||COM SHS USD0.01
||EPS - Basic
||Market Cap (m)
Lifeline Sci Share Discussion Threads
Showing 151 to 174 of 175 messages
|Agreed. Had a few more at 299p. 10% in 2 months provided the £ doesn't strengthen.|
|Well £ v $ exchange rate certainly making this look more attractive.
Offer price now up to £3.32 at the current exchange rate $1.23....over 12% more than the current mid.
|No surprise and they couldn't even be bothered to show the actual votes|
|All resolutions passed.|
|Offer price moved up to £3.18 at the current exchange rate $1.284/£|
|Pleased to say that Hargreave Lansdown are letting me vote on this.|
|You can ask your nominee broker to vote for you,the like of HL will do it for you but some may charge|
|As far as I can see as a nominee holder I am unable to vote (not that I expect it matters much) is that correct?|
|I take the downbeat outlook statement with a pinch of salt: it may be at the more cautious end of the range given the bid.|
Agree. Somerset lad posed a number of valid questions/musings a few posts back.
Exchange Rate currently 1.30 which would equate to a £3.14 takeout.
Disappointed like many others here as was looking forward to the launch of the LifePort Liver Transporter System & perhaps a NASDAQ listing down the line.
|1H just confirms offer far too low!!!
Not given up hope, a few hurdles still to jump!
GL - SJ|
|From pp. 36 and 37 of the Shareholder Circular:
"In addition to an increase in Mr. Kravitz’s base salary from $390,000 to $440,000 (which is Mr. Kravitz’s first salary increase in five years), such agreement provides for the potential to earn bonuses of up to $700,000 upon achievement of certain milestones and eligibility for annual “stretch”; bonuses. Further, upon consummation of the transactions contemplated by the Merger Agreement, Mr. Kravitz will receive a deal bonus of $1,433,000... Mr. Kravitz will also be receiving an equity incentive through the issuance of additional limited partnership interests in Holdco allowing him to participate in 7% or more of the profits and appreciation of Holdco."
I too would like to benefit from the growth I expect and will therefore be voting against the proposal to delist, as I believe it is in the better interests of shareholders for LSIC to remain independent and list on Nasdaq.|
|At todays 133 exchange rate we get £3.06|
|Bit more positive action today with offer now at 303 for 1k...Another bid is still a possibility even if small.|
|They did say they were previously in talks with potential buyers so i presume that's the plural of the meaning buyers, I wonder what the other interested parties make of this?|
|We live in hope. IC2 for goodness sake stop selling everything :). If i can buy at 280 I'll take a few more with an easy 10% upside.|
|They are getting this company at an absolute steal. I would have much preferred no takeover at all unless it was a massive premium. There are so few companies that have a real niche in a growing market (with potential for selling into new markets). All this and trading at an undemanding valuation. I would happily have held for years and years. I had high hopes this could be a 10 bagger.
If there was no takeover, the price could have risen another 15% today. The management team at LSIC should be shot for selling this gem of a company for a song. What is the likelihood of a counter bid from someone else? Or is this a done deal?|
|5% in 3 months (max) is 21.5%pa. I'd be v happy with that sort of return albeit with exchange rate risk|
|I have now sold all of my holdings, first batch went at 300p at the open, then I had to wait for the price to come back and sold in two further transactions at 285p and 290p. So on average I was down just 6% from the offer price, I would rather reinvest the cash elsewhere with a the probability that I can make over 5% before December in another opportunity. Overall LSIC was a good investment from December last year, just a shame it didn't end a little better.|
|It would be tricky for another bidder to come in unless the irrevocables are soft.
And if the bankers have done their job, it should have been offered already to all potential buyers.
On balance, I prefer battlebus2's idea of a Nasdaq listing to crystallise the value and will therefore be voting my half a percent against the proposal to delist.|
|Re TS both Revenue and PBT significantly ahead of my forecasts at $18m and $2m
With a significant 2H weighting for the past two years my model now forecasts $8m PBT for 2016
With zero tax a PE of less than 10!
Add to that geographical growth of Kidney Transporter sales
And whole new market (at least as big?) for new Liver Transporter - imminent
And potential for other organ preservation
And patent protection
And you have a company worth a lot more than $88m (inc options)
Hence I think AN Other bidder might emerge (perhaps that is the strategy - flush them out?)|
|There isn't one, a Nasdaq listing would have been a better option than this. Spot on Somerset Lad.|
|There is still value in the tax losses as the business sis going to be run as a stand alone subsidiary of the potential bidder.
When the full offer document comes out I will be very interested in Panmure Gordon's opinion on the offer price.
I can see no operational reason for this takeover|
|A few idle questions:
- Why is LSI selling? They thought the business was terribly undervalued at around £2 / $3 (at £1 = $1.50), yet they're selling out for a $1 premium.
- How did they get a fairness opinion when the broker reports suggested a much higher valuation?
- Did they shop the business effectively in the US, where there was value in the accumulated tax losses?
- Are the 40% irrevocables hard or soft? Of course, if the bankers have shopped the business around properly there won't be other bidders.
- Was a higher offer available without the CEO remaining in post?
- What would the share price have been if there had been no strategic review, and we'd simply had improving trading for kidney and ongoing progress with liver? 260p?|